Functional variants of the genes involved in neurodevelopment and susceptibility to schizophrenia in an Armenian population

Human Immunology

Volumn 72, Issue 9, 2011, Pages 746-748

  Zakharyan, Roksana ^a,b   Boyajyan, Anna ^a   Arakelyan, Arsen ^a   Gevorgyan, Anaida ^c   Mrazek, Frantisek ^b   Petrek, Martin ^b  

^a INSTITUTE OF MOLECULAR BIOLOGY   (Armenia)

^b PALACKÝ UNIVERSITY   (Czech Republic)

^c Nork Clinic attached to the Psychiatric Medical Center   (Armenia)

Author keywords

Brain derived neurotrophic factor; Netrin G1; Neurodevelopment; Schizophrenia; Single nucleotide polymorphisms

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; NETRIN; NETRIN G1; UNCLASSIFIED DRUG;

ADULT; ARMENIA; ARTICLE; CONTROLLED STUDY; FUNCTIONAL GENOMICS; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; NERVE CELL DIFFERENTIATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK FACTOR; SCHIZOPHRENIA;

ADULT; AGE OF ONSET; AGED; ARMENIA; BRAIN-DERIVED NEUROTROPHIC FACTOR; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPING TECHNIQUES; GPI-LINKED PROTEINS; HUMANS; MALE; MIDDLE AGED; NERVE TISSUE PROTEINS; NERVOUS SYSTEM; POLYMORPHISM, GENETIC; SCHIZOPHRENIA;

EID: 84860397036     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2011.05.018     Document Type: Article

References (30)

1. Fatemil S.H., Folsom T.D. The neurodevelopmental hypothesis of schizophrenia, revisited. Schizophr Bull 2009, 35:528-548.
2. Hakobyan S., Boyajyan A., Sim R.B. Classical pathway complement activity in schizophrenia. Neurosci Lett 2005, 374:35-37.
3. Potvin S., Stip E., Sepehry A.A., Gendron A., Bah R., Kouassi E. Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review. Biol Psychiatry 2008, 63:801-808.
4. Boyajyan A., Khoyetsyan A., Tsakanova G., Sim R.B. Cryoglobulins as indicators of upregulated immune response in schizophrenia. Clin Biochem 2008, 41:355-360.
5. Boyajyan A., Khoyetsyan A., Chavushyan A. Alternative complement pathway in schizophrenia. Neurochem Res 2010, 35:894-898.
6. Le Strat Y., Ramoz N., Gorwood P. The role of genes involved in neuroplasticity and neurogenesis in the observation of a gene-environment interaction (GxE) in schizophrenia. Curr Mol Med 2009, 9:506-518.
7. Stefansson H., Ophoff R.A., Steinberg S., et al. Common variants conferring risk of schizophrenia. Nature 2009, 460:744-747.
8. Moore S.W., Tessier-Lavigne M., Kennedy T.E. Netrins and their receptors. Adv Exp Med Biol 2007, 621:17-31.
9. Padhan K., Varma R. Immunological synapse: a multi-protein signalling cellular apparatus for controlling gene expression. Immunology 2010, 129:322-328.
10. Takamatsu H., Okuno T., Kumanogoh A. Regulation of immune cell responses by semaphorins and their receptors. Cell Mol Immunol 2010, 7:83-88.
11. Cunha C., Brambilla R., Thomas K.L. A simple role for BDNF in learning and memory?. Front J Mol Neurosci 2010, 3:1.
12. Stanisz A.M., Stanisz J.A. Nerve growth factor and neuroimmune interactions in inflammatory diseases. Ann N Y Acad Sci 2000, 917:268-272.
13. Arinami T., Ohtsuki T., Ishiguro H., et al. Genomewide high-density SNP linkage analysis of 236 Japanese families supports the existence of schizophrenia susceptibility loci on chromosomes 1p, 14q, and 20p. Am J Hum Genet 2005, 77:937-944.
14. Suarez B.K., Duan J., Sanders A.R., et al. Genomewide linkage scan of 409 European-ancestry and African American families with schizophrenia: suggestive evidence of linkage at 8p23.3-p21.2 and 11p13.1-q14.1 in the combined sample. Am J Hum Genet 2006, 78:315-333.
15. Fukasawa M., Aoki M., Yamada K., et al. Case-control association study of human netrin G1 gene in Japanese schizophrenia. J Med Dent Sci 2004, 51:121-128.
16. Ohtsuki T., Horiuchi Y., Koga M., et al. Association of polymorphisms in the haplotype block spanning the alternatively spliced exons of the NTNG1 gene at 1p13.3 with schizophrenia in Japanese populations. Neurosci Lett 2008, 435:194-197.
17. Egan M.F., Kojima M., Callicott J.H., et al. The BDNF Val66Met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 2003, 112:257-269.
18. Cattaneo A., Bocchio-Chiavetto L., Zanardini R., et al. BDNF Val66Met polymorphism and protein levels in amniotic fluid. BMC Neurosci 2010, 11:16.
19. Pezawas L., Verchinski B.A., Mattay V.S., et al. The brain-derived neurotrophic factor val66met polymorphism and variation in human cortical morphology. J Neurosci 2004, 24:10099-10102.
20. Buckley P.F., Pillai A., Howell K.R. Brain-derived neurotrophic factor: findings in schizophrenia. Curr Opin Psychiatry 2011, 24:122-127.
21. Numata S., Ueno S., Iga J., Yamauchi K., et al. Brain-derived neurotrophic factor (BDNF) Val66Met polymorphism in schizophrenia is associated with age at onset and symptoms. Neurosci Lett 2006, 401:1-5.
22. Spalletta G., Morris D.W., Angelucci F., et al. BDNF Val66Met polymorphism is associated with aggressive behavior in schizophrenia. Eur Psychiatry 2010, 25:311-313.
23. Gratacòs M., González J.R., Mercader J.M., et al. Brain-derived neurotrophic factor Val66Met and psychiatric disorders: meta-analysis of case-control studies confirm association to substance-related disorders, eating disorders, and schizophrenia. Biol Psychiatry 2007, 61:911-922.
24. Kanazawa T., Glatt S.J., Kia-Keating B., Yoneda H., Tsuang M.T. Meta-analysis reveals no association of the Val66Met polymorphism of brain-derived neurotrophic factor with either schizophrenia or bipolar disorder. Psychiatr Genet 2007, 17:165-170.
25. Sambrook J., Russell D.W. Molecular Cloning: A Laboratory Manual 2001, Cold Spring Harbor Laboratory Press, New York, ch 8. 3rd ed.
26. Bunce M., O'Neil C.M., Barnado M.C., et al. Phototyping: comprehensive DNA typing for HLA-A, B, C, DRB3, DRB4, DRB5&DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP). Tissue Antigens 1995, 6:355-367.
27. Lalouel J.M., Rohrwasser A. Power and replication in case-control studies. Am J Hypertens 2002, 15:201-205.
28. Chao H.M., Kao H.T., Porton B. BDNF Val66Met variant and age of onset in schizophrenia. Am J Med Genet B Neuropsychiatr Genet 2008, 147B:505-506.
29. Malla A.K., Norman R.M.G., Manchanda R., et al. One year outcome in first episode psychosis: influence of DUP and other predictors. Schizophr Res 2002, 54:231-242.
30. Douaud G., Mackay C., Andersson J., et al. Schizophrenia delays and alters maturation of the brain in adolescence. Brain 2009, 132:2437-2448.